000			01481 a2200397 4500
005			20250511125451.0
264		0	_c19770331
008			197703s 0 0 eng d
022			_a0026-0495
024	7		_a10.1016/0026-0495(77)90073-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aChesnut, C H
245	0	0	_aEffect of methandrostenolone on postmenopausal bone wasting as assessed by changes in total bone mineral mass. _h[electronic resource]
260			_bMetabolism: clinical and experimental _cMar 1977
300			_a267-77 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAged
650	0	4	_aBody Composition _xdrug effects
650	0	4	_aBone and Bones _xanalysis
650	0	4	_aCalcium _xanalysis
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Evaluation
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMenopause
650	0	4	_aMethandrostenolone _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNeutron Activation Analysis
650	0	4	_aOsteoporosis _xdrug therapy
650	0	4	_aPlacebos
700	1		_aNelp, W B
700	1		_aBaylink, D J
700	1		_aDenney, J D
773	0		_tMetabolism: clinical and experimental _gvol. 26 _gno. 3 _gp. 267-77
856	4	0	_uhttps://doi.org/10.1016/0026-0495(77)90073-7 _zAvailable from publisher's website
999			_c344547 _d344547